Literature DB >> 24316761

Roles of Toll-like receptors in transplantation.

Huiling Wu1, Steven J Chadban.   

Abstract

PURPOSE OF REVIEW: Beyond their crucial role in host defence against invading pathogens, Toll-like receptors (TLRs) are now known to be key mediators of the 'sterile' innate immune response triggered by tissue injury. Here, we will review recent evidence examining the role of TLRs in determining the fate of the transplanted organ. RECENT
FINDINGS: Experimental studies have delineated a crucial role for TLRs in the pathogenesis of ischaemia-reperfusion injury (IRI). Following transplantation, experimental models and observational human studies have confirmed TLRs as mediators of IRI but also suggest that TLRs modify the subsequent adaptive alloimmune response, which determines whether an organ is rejected or accepted.
SUMMARY: As a key determinant of organ damage following ischaemia-reperfusion and as a modulator of the adaptive alloimmune response, we propose that TLR-mediated innate immune responses represent a potential therapeutic target to improve organ outcomes following transplantation.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24316761     DOI: 10.1097/MOT.0000000000000038

Source DB:  PubMed          Journal:  Curr Opin Organ Transplant        ISSN: 1087-2418            Impact factor:   2.640


  11 in total

Review 1.  Aging and the immune response to organ transplantation.

Authors:  Monica M Colvin; Candice A Smith; Stefan G Tullius; Daniel R Goldstein
Journal:  J Clin Invest       Date:  2017-05-15       Impact factor: 14.808

2.  Haptoglobin enhances cardiac transplant rejection.

Authors:  Hua Shen; Elizabeth Heuzey; Daniel N Mori; Christine K Wong; Christopher M Colangelo; Lisa M Chung; Can Bruce; Ilya B Slizovskiy; Carmen J Booth; Daniel Kreisel; Daniel R Goldstein
Journal:  Circ Res       Date:  2015-03-23       Impact factor: 17.367

Review 3.  Role of TLRs and DAMPs in allograft inflammation and transplant outcomes.

Authors:  Faouzi Braza; Sophie Brouard; Steve Chadban; Daniel R Goldstein
Journal:  Nat Rev Nephrol       Date:  2016-03-30       Impact factor: 28.314

Review 4.  Innate immune mechanisms in transplant allograft vasculopathy.

Authors:  Dan Jane-Wit; Caodi Fang; Daniel R Goldstein
Journal:  Curr Opin Organ Transplant       Date:  2016-06       Impact factor: 2.640

5.  Low Pre-Transplant Caveolin-1 Serum Concentrations Are Associated with Acute Cellular Tubulointerstitial Rejection in Kidney Transplantation.

Authors:  Florian Emmerich; Stefan Zschiedrich; Christine Reichenbach-Braun; Caner Süsal; Susana Minguet; Marie-Christin Pauly; Maximilian Seidl
Journal:  Molecules       Date:  2021-04-30       Impact factor: 4.411

Review 6.  Toll-like receptors in immunity and inflammatory diseases: Past, present, and future.

Authors:  Kumar Vijay
Journal:  Int Immunopharmacol       Date:  2018-05-04       Impact factor: 4.932

7.  Bacterial products in donor airways prevent the induction of lung transplant tolerance.

Authors:  Satona Tanaka; Jason M Gauthier; Yuriko Terada; Tsuyoshi Takahashi; Wenjun Li; Kohei Hashimoto; Ryuji Higashikubo; Ramsey R Hachem; Ankit Bharat; Jon H Ritter; Ruben G Nava; Varun Puri; Alexander S Krupnick; Andrew E Gelman; Daniel Kreisel
Journal:  Am J Transplant       Date:  2020-09-05       Impact factor: 8.086

8.  The protective effects of exogenous spermine on renal ischemia-reperfusion injury in rats.

Authors:  Bo Yan; Shao-Ju Min; Bin Xu; Cheng Zhang; Jun Pei; Wei Zhang; Guang-Heng Luo
Journal:  Transl Androl Urol       Date:  2021-05

9.  ADAR1 Suppresses the Activation of Cytosolic RNA-Sensing Signaling Pathways to Protect the Liver from Ischemia/Reperfusion Injury.

Authors:  Hui Wang; Guoliang Wang; Liyong Zhang; Junbin Zhang; Jinxiang Zhang; Qingde Wang; Timothy R Billiar
Journal:  Sci Rep       Date:  2016-02-01       Impact factor: 4.379

10.  Prevention of allograft rejection in heart transplantation through concurrent gene silencing of TLR and Kinase signaling pathways.

Authors:  Hongmei Wang; Xusheng Zhang; Xiufen Zheng; Zhu Lan; Jun Shi; Jifu Jiang; Terry Zwiep; Qing Li; Douglas Quan; Zhu-Xu Zhang; Weiping Min
Journal:  Sci Rep       Date:  2016-09-23       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.